303 related articles for article (PubMed ID: 8685642)
21. A randomized, double-blind comparison of itraconazole oral solution and fluconazole tablets in the treatment of esophageal candidiasis.
Wilcox CM; Darouiche RO; Laine L; Moskovitz BL; Mallegol I; Wu J
J Infect Dis; 1997 Jul; 176(1):227-32. PubMed ID: 9207371
[TBL] [Abstract][Full Text] [Related]
22. Treatment of fluconazole-refractory oropharyngeal candidiasis with itraconazole oral solution in HIV-positive patients.
Saag MS; Fessel WJ; Kaufman CA; Merrill KW; Ward DJ; Moskovitz BL; Thomas C; Oleka N; Guarnieri JA; Lee J; Brenner-Gati L; Klausner M
AIDS Res Hum Retroviruses; 1999 Nov; 15(16):1413-7. PubMed ID: 10555103
[TBL] [Abstract][Full Text] [Related]
23. Randomized comparison between fluconazole and itraconazole for the treatment of candidemia in a pediatric intensive care unit: a preliminary study.
Mondal RK; Singhi SC; Chakrabarti A; M J
Pediatr Crit Care Med; 2004 Nov; 5(6):561-5. PubMed ID: 15530193
[TBL] [Abstract][Full Text] [Related]
24. [Comparative study of itraconazole and fluconazole therapy in vaginal candidosis].
Vacheva-Dobrevski R; Kovachev S; Nacheva A; Stoev S; Vasilev N
Akush Ginekol (Sofiia); 2004; 43(1):20-3. PubMed ID: 15168649
[TBL] [Abstract][Full Text] [Related]
25. [Therapy of candidiasis and cryptococcosis in AIDS].
Just-Nübling G
Mycoses; 1994; 37 Suppl 2():56-63. PubMed ID: 7609745
[TBL] [Abstract][Full Text] [Related]
26. A double-blind comparison of itraconazole oral solution and fluconazole capsules for the treatment of oropharyngeal candidiasis in patients with AIDS.
Phillips P; De Beule K; Frechette G; Tchamouroff S; Vandercam B; Weitner L; Hoepelman A; Stingl G; Clotet B
Clin Infect Dis; 1998 Jun; 26(6):1368-73. PubMed ID: 9636865
[TBL] [Abstract][Full Text] [Related]
27. Itraconazole vs fluconazole for the treatment of uncomplicated acute vaginal and vulvovaginal candidiasis in nonpregnant women: a metaanalysis of randomized controlled trials.
Pitsouni E; Iavazzo C; Falagas ME
Am J Obstet Gynecol; 2008 Feb; 198(2):153-60. PubMed ID: 18068146
[TBL] [Abstract][Full Text] [Related]
28. The treatment of oral candidiasis in a cohort of South African HIV/AIDS patients.
Blignaut E; Botes ME; Nieman HL
SADJ; 1999 Dec; 54(12):605-8. PubMed ID: 16892568
[TBL] [Abstract][Full Text] [Related]
29. A randomized study of the use of fluconazole in continuous versus episodic therapy in patients with advanced HIV infection and a history of oropharyngeal candidiasis: AIDS Clinical Trials Group Study 323/Mycoses Study Group Study 40.
Goldman M; Cloud GA; Wade KD; Reboli AC; Fichtenbaum CJ; Hafner R; Sobel JD; Powderly WG; Patterson TF; Wheat LJ; Stein DK; Dismukes WE; Filler SG; ;
Clin Infect Dis; 2005 Nov; 41(10):1473-80. PubMed ID: 16231260
[TBL] [Abstract][Full Text] [Related]
30. [Itraconazole suspension in the treatment of HIV-infected patients with fluconazole-resistant oropharyngeal candidiasis and esophagitis].
Eichel M; Just-Nübling G; Helm EB; Stille W
Mycoses; 1996; 39 Suppl 1():102-6. PubMed ID: 8767280
[TBL] [Abstract][Full Text] [Related]
31. Candidiasis at ICAAC.
Barr D; Smart T
GMHC Treat Issues; 1995 Oct; 9(10):13. PubMed ID: 11362914
[TBL] [Abstract][Full Text] [Related]
32. Clinical, endoscopic, immunologic, and therapeutic aspects of oropharyngeal and esophageal candidiasis in HIV-infected patients: a survey of 114 cases.
López-Dupla M; Mora Sanz P; Pintado García V; Valencia Ortega E; Uriol PL; Khamashta MA; Aguado AG
Am J Gastroenterol; 1992 Dec; 87(12):1771-6. PubMed ID: 1449139
[TBL] [Abstract][Full Text] [Related]
33. Comparison of itraconazole and ketoconazole in HIV-positive patients with oropharyngeal or esophageal candidiasis. Human Immunodeficiency Virus Itraconazole Ketoconazole Project Group.
de Repentigny L; Ratelle J
Chemotherapy; 1996; 42(5):374-83. PubMed ID: 8874977
[TBL] [Abstract][Full Text] [Related]
34. [Candida esophagitis treated with a single dose of fluconazole in patients with HIV: presentation of 11 cases].
Roig P; Martínez A; Salavert M; Nieto A; Navarro V; Medina E; Carrasco R
Enferm Infecc Microbiol Clin; 1990 Nov; 8(9):544-7. PubMed ID: 2099854
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic options for the management of oropharyngeal and esophageal candidiasis in HIV/AIDS patients.
Vazquez JA
HIV Clin Trials; 2000; 1(1):47-59. PubMed ID: 11590489
[TBL] [Abstract][Full Text] [Related]
36. [Treatment of esophageal candidiasis with fluconazole in acquired immunodeficiency syndrome. Comparative study of 2 therapeutic schemes].
Gil A; Lavilla P; López Dupla M; Valencia E; Pintado V; Khamashta M; García Puig J; Ortiz-Vázquez J
Med Clin (Barc); 1992 Apr; 98(16):612-7. PubMed ID: 1630165
[TBL] [Abstract][Full Text] [Related]
37. [Oro-esophageal candidiasis resistant to fluconazole in patients with AIDS].
Diz P; Ocampo A; Miralles C; Otero I; Iglesias I; Martínez C
Enferm Infecc Microbiol Clin; 1993 Jan; 11(1):36-9. PubMed ID: 8461371
[TBL] [Abstract][Full Text] [Related]
38. Comparison of single-dose and 7-day fluconazole treatment of fungal esophagitis in alcoholic liver disease.
Péter Z; Horváth Z; Makara M; Telegdy L; Zala J; Zágoni T
Z Gastroenterol; 1996 Jun; 34(6):361-4. PubMed ID: 8767824
[TBL] [Abstract][Full Text] [Related]
39. Liposomal amphotericin B versus the combination of fluconazole and itraconazole as prophylaxis for invasive fungal infections during induction chemotherapy for patients with acute myelogenous leukemia and myelodysplastic syndrome.
Mattiuzzi GN; Estey E; Raad I; Giles F; Cortes J; Shen Y; Kontoyiannis D; Koller C; Munsell M; Beran M; Kantarjian H
Cancer; 2003 Jan; 97(2):450-6. PubMed ID: 12518369
[TBL] [Abstract][Full Text] [Related]
40. A randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients.
Ally R; Schürmann D; Kreisel W; Carosi G; Aguirrebengoa K; Dupont B; Hodges M; Troke P; Romero AJ;
Clin Infect Dis; 2001 Nov; 33(9):1447-54. PubMed ID: 11577374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
